Arterial Thrombosis Flashcards
(20 cards)
Vasculature
- pressurised vascular system is required to perfuse all tissues
- so a hole in vasculature means this pressure drives blood out
Treatments for arterial thrombosis
- relieve pain = nitrates, opioids, beta-blockers
- reperfuse = thrombolytics, precutaneous coronary intervention/coronary angioplasty, bypass surgery
- stop thrombosis = anti-platelet or anti-coagulant agents
Haemostatic system
decreases blood loss
- platelets = cell-based system
- coagulation = protein-based system
coagulation:
- thrombin production
- thrombin forms fibrin
- fibrin forms a mesh
- clot forms outside of vessel
Anti-thrombotics - when to use
before - prevent thrombosis, perhaps in at risk patients (primary intervention)
during ACS - particularly during PCI
after = prevent new thrombi (secondary intervention)
Arterial thrombosis
atherosclerotic plaque –> platelet aggregation –> coagulation –> thrombus
thrombus = clot in the lumen of the vessel
acute coronary syndrome = sudden onset of pain caused by:
- thrombus partly blocking coronary vessel
- or completely blocking vessel
causes decreased blood flow to the cardiac muscle
Platelet structure
- dense core granules
- open canalicular system
- alpha granules
- mitochondria
- no nucleus or DNA
Role of the open canalicular systme
internal structure likely provides reservoir of internal membrane
- detect signals
- adhere to sites
- make changes and adhere to platelets
Platelets and in tact vs damaged blood vessels
in tact blood vessels inhibit platelets
- via NO and PGI2
- conceals subendothelial matrix
platelets adhere to damaged vessels
- exposed subendothelial matrix (collagen, elastin, laminin)
- vWF and fibrinogen are plasma-borne adhesion molecules
Platelet adhesion
interaction between GPIb (platelet) and vWF (plasma)
- can form under high shear
- activation-independent
- fast dissociation
- results in weak intracellular signalling
interaction between GPVI and collagen
- direct interaction
- low affinity
- activation-independent
- results in strong intracellular signalling
interaction between GPIIb/IIIa and vWF
- high affininty
- activation-dependent
- triggers more intracellular signalling
Bernard Soulier syndrome
lack of (or non-functional) GPIb on platelets to interact with vWF
von Willebrand’s disease
lack of vWF in plasma to interact with GPIb on platelets
Glanzmann’s thrombasthenia
lack of (or non-functional) GPIIb/IIIa on platelets to interact with vWF
vWF
von Willebrand’s factor
Platelet activation
- once adhered, massive increase in platelet surface area
- using internal membrane system
- secretion of ADP, ATP and 5-HT
- thromboxane synthesis
- integrin activation
Platelet activation - secretion
- Hermansky-Pudlack syndrome
- inhibited by P2Y12 antagonists
Platelet activation - adhesion
- Glanzmann’s thrombasthenia
- inhibited by GPIIb/IIIa antagonists
Platelet activation - thromboxane synthesis
- inhibited by aspirin
Unstable angina
- partly blocks vessel
- ischaemia
Non-ST segment- elevated myocardial infarction (NSTEMI)
- partly blocks
- ischaemia and necrosis
ST segment-elevated myocardial infarction (STEMI)
- completely blocks
- ischaemia and necrosis